Effect of the HBV Capsid Assembly Inhibitor Bayer 41-4109 on the Intracellular Localization of EGFP-Core Fusion Proteins

Bayer 41-4109 is heteroarylpyrimidine (HAP) which has been identified as potent of HBV capsid assembly inhibitor. The present study was to study effect of Bayer 41-4109 treatment on the intracellular localization of EGFP-Core fusion proteins into HepG2 cells. Three recombinant plasmids of pEGFP-Core...

Full description

Bibliographic Details
Main Authors: Aris Haryanto, Nastiti Wijayanti, Michael Kann
Format: Article
Language:English
Published: Universitas Gadjah Mada, Yogyakarta 2007-12-01
Series:Indonesian Journal of Biotechnology
Online Access:https://jurnal.ugm.ac.id/ijbiotech/article/view/7775

Similar Items